Acute Reversible Cardiomyopathy and Thromboembolism After Cisplatin and 5-Fluorouracil Chemotherapy
Authors:
- Hemalatha VasireddyHVHemalatha Vasireddy
- Anita KuruvillaAKAnita Kuruvilla
- Boris GambarinBGBoris Gambarin
- Majesh MakanMMMajesh Makan
- 1 October 2000
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 51 (10) , 873-878
Abstract
Acute development of cardiomyopathy and occlusive thromboembolic events following cisplatin and 5-fluorouracil (5-FU) is rare but frequently lethal. The authors report the successful management of such an event in a 52-year-old man with squamous cell carcinoma of the soft palate. The possible pathophysiological mechanisms are discussed.Keywords
This publication has 22 references indexed in Scilit:
- Acute mesenteric ischaemia associated with 5-FU, cisplatin and vincristine chemotherapyClinical Oncology, 1996
- Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin CEuropean Journal of Cancer, 1996
- 5-Fluorouracil cardiotoxicity with left ventricular dysfunction under different dosing regimensThe American Journal of Cardiology, 1995
- Acute Cardiac and Renal Failure after 5-FU and Cisplatin TreatmentNephron, 1991
- Acute myocardiotoxicity during 5-fluorouracil therapyIntensive Care Medicine, 1990
- Acute Coronary Events Following Cisplatin-Based ChemotherapyCancer Investigation, 1990
- 5-Fluorouracil Cardiotoxicity: Left Ventricular Dysfunction and Effect of Coronary VasodilatorsThe American Journal of the Medical Sciences, 1987
- Increased embolic risk in patients with left ventricular thrombi.Circulation, 1987
- Persistent intracardiac thrombi and systemic embolization despite anticoagulant therapyAmerican Heart Journal, 1985
- Fluorouracil cardiotoxicity.BMJ, 1978